What is ANI Pharmaceuticals, Inc.'s Market Cap?

ANI Pharmaceuticals, Inc.'s Market Cap is $1.6B, based on as-reported figures from SEC (XBRL) filings.

What is ANI Pharmaceuticals, Inc.'s Enterprise Value?

ANI Pharmaceuticals, Inc.'s Enterprise Value is $1.6B, based on as-reported figures from SEC (XBRL) filings.

What is ANI Pharmaceuticals, Inc.'s Trailing P/E?

ANI Pharmaceuticals, Inc.'s Trailing P/E is 14.9×, based on as-reported figures from SEC (XBRL) filings.

What is ANI Pharmaceuticals, Inc.'s Price / Sales?

ANI Pharmaceuticals, Inc.'s Price / Sales is 1.6×, based on as-reported figures from SEC (XBRL) filings.

What is ANI Pharmaceuticals, Inc.'s EV / Revenue?

ANI Pharmaceuticals, Inc.'s EV / Revenue is 1.6×, based on as-reported figures from SEC (XBRL) filings.

What is ANI Pharmaceuticals, Inc.'s EV / EBITDA?

ANI Pharmaceuticals, Inc.'s EV / EBITDA is 6.6×, based on as-reported figures from SEC (XBRL) filings.

What is ANI Pharmaceuticals, Inc.'s Revenue (TTM)?

ANI Pharmaceuticals, Inc.'s Revenue (TTM) is $978.4M, based on as-reported figures from SEC (XBRL) filings.

What is ANI Pharmaceuticals, Inc.'s Net Income (TTM)?

ANI Pharmaceuticals, Inc.'s Net Income (TTM) is $108.0M, based on as-reported figures from SEC (XBRL) filings.

What is ANI Pharmaceuticals, Inc.'s EBITDA?

ANI Pharmaceuticals, Inc.'s EBITDA is $236.2M, based on as-reported figures from SEC (XBRL) filings.

What is ANI Pharmaceuticals, Inc.'s Diluted EPS (TTM)?

ANI Pharmaceuticals, Inc.'s Diluted EPS (TTM) is 4.70, based on as-reported figures from SEC (XBRL) filings.

ANI Pharmaceuticals, Inc. (ANIP) Financial Statements

ANI Pharmaceuticals, Inc.

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001S9DR85

XNAS · usd

70.23▼ 1.00 (-1.40%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close71.23

Day's Range70.16 – 71.84

52-Week Range70.15 – 99.50

Volume253.2K

Avg Volume378.8K

Share Statistics

Shares Outstanding

Employees970

ExchangeXNAS

Listed1999-09-13

Share count as of July 31, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about ANI Pharmaceuticals, Inc. (ANIP)

What is ANI Pharmaceuticals, Inc.'s Market Cap?: ANI Pharmaceuticals, Inc.'s Market Cap is $1.6B, based on as-reported figures from SEC (XBRL) filings.
What is ANI Pharmaceuticals, Inc.'s Enterprise Value?: ANI Pharmaceuticals, Inc.'s Enterprise Value is $1.6B, based on as-reported figures from SEC (XBRL) filings.
What is ANI Pharmaceuticals, Inc.'s Trailing P/E?: ANI Pharmaceuticals, Inc.'s Trailing P/E is 14.9×, based on as-reported figures from SEC (XBRL) filings.
What is ANI Pharmaceuticals, Inc.'s Price / Sales?: ANI Pharmaceuticals, Inc.'s Price / Sales is 1.6×, based on as-reported figures from SEC (XBRL) filings.
What is ANI Pharmaceuticals, Inc.'s EV / Revenue?: ANI Pharmaceuticals, Inc.'s EV / Revenue is 1.6×, based on as-reported figures from SEC (XBRL) filings.
What is ANI Pharmaceuticals, Inc.'s EV / EBITDA?: ANI Pharmaceuticals, Inc.'s EV / EBITDA is 6.6×, based on as-reported figures from SEC (XBRL) filings.
What is ANI Pharmaceuticals, Inc.'s Revenue (TTM)?: ANI Pharmaceuticals, Inc.'s Revenue (TTM) is $978.4M, based on as-reported figures from SEC (XBRL) filings.
What is ANI Pharmaceuticals, Inc.'s Net Income (TTM)?: ANI Pharmaceuticals, Inc.'s Net Income (TTM) is $108.0M, based on as-reported figures from SEC (XBRL) filings.
What is ANI Pharmaceuticals, Inc.'s EBITDA?: ANI Pharmaceuticals, Inc.'s EBITDA is $236.2M, based on as-reported figures from SEC (XBRL) filings.
What is ANI Pharmaceuticals, Inc.'s Diluted EPS (TTM)?: ANI Pharmaceuticals, Inc.'s Diluted EPS (TTM) is 4.70, based on as-reported figures from SEC (XBRL) filings.